Tyra Biosciences, Inc. TYRA Proceeds From Issuance Of Common Stock Under Benefit Plans
Proceeds From Issuance Of Common Stock Under Benefit Plans at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept tyra:ProceedsFromIssuanceOfCommonStockUnderBenefitPlans.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s proceeds from issuance of common stock under benefit plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s proceeds from issuance of common stock under benefit plans?
- Tyra Biosciences, Inc. (TYRA) reported proceeds from issuance of common stock under benefit plans of $12.53M in Q1 2026.
- How has Tyra Biosciences, Inc.'s proceeds from issuance of common stock under benefit plans changed year-over-year?
- Tyra Biosciences, Inc.'s proceeds from issuance of common stock under benefit plans increased by 472.9% year-over-year, from $2.19M to $12.53M.
- What is the long-term trend for Tyra Biosciences, Inc.'s proceeds from issuance of common stock under benefit plans?
- Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s proceeds from issuance of common stock under benefit plans has grown at a 97.1% compound annual growth rate (CAGR), from $537K to $8.1M.
- What does proceeds from issuance of common stock under benefit plans mean?
- This represents the cash inflows received by the company from the issuance of common stock to employees or directors through benefit plans such as stock option exercises or employee stock purchase programs. It serves as a measure of capital raised through equity-based compensation arrangements.